RA Capital Management - ACHILLES THERAPEUTICS PLC ownership

ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 19 filers reported holding ACHILLES THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
RA Capital Management ownership history of ACHILLES THERAPEUTICS PLC
ValueSharesWeighting
Q4 2022$1,447,051
-87.2%
1,607,834
-67.9%
0.03%
-88.0%
Q3 2022$11,333,000
-10.3%
5,014,6870.0%0.24%
-28.2%
Q2 2022$12,637,000
-14.3%
5,014,6870.0%0.34%
+4.7%
Q1 2022$14,743,000
-41.3%
5,014,6870.0%0.32%
-27.3%
Q4 2021$25,124,000
-35.7%
5,014,6870.0%0.44%
-18.1%
Q3 2021$39,064,000
-20.4%
5,014,6870.0%0.54%
-31.3%
Q2 2021$49,094,000
+113.6%
5,014,687
+261.1%
0.79%
+127.1%
Q1 2021$22,986,0001,388,8880.35%
Other shareholders
ACHILLES THERAPEUTICS PLC shareholders Q1 2023
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 11,086,909$10,087,97915.03%
Artal Group S.A. 2,255,375$2,0520.09%
Redmile Group, LLC 1,608,089$1,463,2000.07%
Forefront Analytics, LLC 78,169$71,1260.04%
Baker Brothers Advisors 2,557,149$2,326,7500.01%
Point72 Asset Management, L.P. 1,413,809$1,286,4250.00%
XTX Topco Ltd 21,084$19,1840.00%
Coppell Advisory Solutions LLC 1,000$5,5600.00%
Renaissance Technologies 437,528$3980.00%
JPMORGAN CHASE & CO 989$9000.00%
View complete list of ACHILLES THERAPEUTICS PLC shareholders